PATENT CLAIM ANALYSIS

Application Number: 15985729
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "186100"]

Abstract:
A rapid test for a qualitative and/or quantitative assay of antibodies present in body fluid against human papilloma viruses (HPV) includes mixing a specimen of body fluid with a reagent which essentially comprises a predetermined quantity of physiologically acting liquid and a predetermined quantity of at least one HPV-specific antigen. The mixture is fed to an analysis which utilizes a change that is at least one of measurable or perceivable by a user.

Claim (Index 16):
An analysis system for a device for carrying out a rapid test for at least one of a qualitative or quantitative assay of antibodies present in body fluid against human papilloma virus type 16 (HPV16),\n wherein the analysis system (i) is configured for accommodation of a predetermined quantity of a substrate containing a reagent and a body fluid and (ii) utilizes a change that is effected by the substrate that is at least one of measurable or perceivable by a user, wherein the reagent essentially comprises a predetermined quantity of physiologically acting liquid and a predetermined quantity of at least one antigen, and wherein the antigen is reactive to antibodies present in the body fluid that are specific against HPV16L1 protein (HPV16L1 specific antibodies), wherein the analysis system contains: (a) a conjugate that essentially comprises a predetermined quantity of at least one molecule and a substance that causes a reaction that is at least one measurable or perceivable by a user or in the event of spatial accumulation results in a change which is at least one of measurable or perceivable by a user, wherein the molecule of the conjugate is specific against HPV16L1 protein and binds to the antigen when the antigen is reactive with respect to the molecule of the conjugate, (b) a carrier medium ( 16 ) onto or into which the applied quantity of substrate of the receptacle can flow in the direction of at least one three-dimensional axis ( 20 ), (c) a predetermined quantity of at least one trapping molecule which is fixed on a predetermined first point or a predetermined first region ( 26 ) of the carrier medium ( 16 ) and binds to the antigen when the antigen is reactive with respect to the trapping molecule, wherein the trapping molecule and the molecule of the conjugate are identical to one another in such a way that both undergo binding to the antigen when the antigen is reactive with respect to the HPV16L1-specific antibodies.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.35088
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15361556', '13989804', '10778936', '10008524', '12318138']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6972148988187442
- 35 USC 102 Novelty (BERT): 0.5457451240039289
- Combined Prediction Score: 0.6820679213372627
- Mean Citation Score: 234.559444
- Max Citation Score: 376.83997
- Similarity Product: 337.240140293479

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test